Article in Journal of clinical medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registry
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what money
Authors and funding
15 authors.
Luis Ortega-PazDivision of Cardiology, College of Medicine, University of Florida, Jacksonville, FL 32206, USA.ORCID 0000-0002-9567-3253
Claudio LaudaniDivision of Cardiology, College of Medicine, University of Florida, Jacksonville, FL 32206, USA.ORCID 0000-0001-5467-7402
Carlos Igor MorrCardiology Department, Cardiovascular Clinic Institute, Hospital Clínic Barcelona, University of Barcelona, 08036 Barcelona, Spain.ORCID 0000-0001-6336-3501
Alessandro SionisCardiological Intensive Care Unit, Cardiology Department, Hospital de la Santa Creu i Sant Pau, Sant Pau Biomedical Research Institute (IIB Sant Pau), 08041 Barcelona, Spain.ORCID 0000-0003-0843-9512
Pablo Vidal-CalesCardiology Department, Cardiovascular Clinic Institute, Hospital Clínic Barcelona, University of Barcelona, 08036 Barcelona, Spain.
Victor ArevalosCardiology Department, Cardiovascular Clinic Institute, Hospital Clínic Barcelona, University of Barcelona, 08036 Barcelona, Spain.ORCID 0000-0001-9525-1133
Rut AndreaCardiology Department, Cardiovascular Clinic Institute, Hospital Clínic Barcelona, University of Barcelona, 08036 Barcelona, Spain.ORCID 0000-0002-8409-5013
Oriol De DiegoCardiology Department, Cardiovascular Clinic Institute, Hospital Clínic Barcelona, University of Barcelona, 08036 Barcelona, Spain.ORCID 0000-0002-8476-7094
Emilio OrtegaCardiology Department, Cardiovascular Clinic Institute, Hospital Clínic Barcelona, University of Barcelona, 08036 Barcelona, Spain.ORCID 0000-0002-2217-8905
Ana Paula DantasDepartment of Biomedical Sciences, Institut de Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), University of Barcelona, 08193 Barcelona, Spain.
Dominick J AngiolilloDivision of Cardiology, College of Medicine, University of Florida, Jacksonville, FL 32206, USA.ORCID 0000-0001-8451-2131
Manel SabatéCardiology Department, Cardiovascular Clinic Institute, Hospital Clínic Barcelona, University of Barcelona, 08036 Barcelona, Spain.ORCID 0000-0002-2316-3705
Jose T Ortiz-PérezCardiology Department, Cardiovascular Clinic Institute, Hospital Clínic Barcelona, University of Barcelona, 08036 Barcelona, Spain.ORCID 0000-0001-8043-6055
Salvatore BrugalettaCardiology Department, Cardiovascular Clinic Institute, Hospital Clínic Barcelona, University of Barcelona, 08036 Barcelona, Spain.ORCID 0000-0001-5845-1435
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.
Effect of Dapagliflozin on Myocardial Fibrosis After STEMI: A Double-Blind, Placebo-Controlled Randomized Trial. · full record | Socratic